Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis

View source ↗

Summary

Pfizer is conducting an observational study to learn about long-term use of Velsipity in patients with ulcerative colitis; the study is currently NOT_YET_RECRUI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VELSIPITY (ETRASIMOD)

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis (UC) | Status: NOT_YET_RECRUITING